BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Immunocore Limited 

57c Milton Park

Abingdon  Oxon  OX14 4RX  United Kingdom
Phone: 44-0-1235-438600 Fax: 44-0-1235-438601


SEARCH JOBS




Industry
Biotechnology






 Company News
Immunocore Limited Announces Positive Clinical Trial Data For Novel First-in-Class Immunotherapy At AACR Annual Meeting 2015 4/20/2015 10:22:10 AM
Immunocore Limited And MedImmune (AZN) Announce New Collaboration To Conduct Immuno-Oncology Combination Trails In Melanoma 4/16/2015 6:33:40 AM
Immunocore Limited To Present IMCgp100 Clinical Trial Data At American Association for Cancer Research Annual Meeting 2015 4/8/2015 7:59:09 AM
Immunocore Limited Appoints Dr. Christina Coughlin As Chief Medical Officer 4/1/2015 10:54:57 AM
Immunocore Limited Appoints Professor Sir John Bell To Its Board Of Directors 3/30/2015 12:56:22 PM
Immunocore Limited To Present At Cowen and Company 35th Annual Health Care Conference 3/2/2015 10:29:36 AM
Immunocore Limited Appoints Dr Eliot Forster As Chief Executive Officer 1/12/2015 11:46:12 AM
Eli Lilly and Company (LLY) Inks $45 Million Immunotherapy Development Deal With Immunocore Limited 7/16/2014 7:45:35 AM
MediGene, Inc. Converts Immunocore Limited Shareholding Into Share Class With Upside Potential 6/24/2014 11:19:20 AM
Immunocore Limited Announces Re-Organisation Of Its Executive Management To Support Business Growth 3/26/2014 11:02:03 AM
123